| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:3032.)
© 2002 American Heart Association, Inc.
Basic Science Reports |

From the Department of Chemistry and Biochemistry, Ohio University, Athens (S.H., A.J., T.M.); and the Ludwig Boltzmann-Institute for Experimental and Clinical Traumatology, Vienna (H.G., G.S.), and the Department of Vascular Surgery, University of Vienna (C.N., A.F., J.N., I.H.), Vienna, Austria.
Correspondence to Tadeusz Malinski, PhD, Department of Chemistry and Biochemistry, 350 W State St, Ohio University, Athens, OH 45701-2970. E-mail malinski{at}ohio.edu
Background Peroxynitrite generated from nitric oxide (NO) and superoxide (O2-) contributes to ischemia/reperfusion (I/R) injury. Feedback inhibition of endothelial NO synthase by NO may inhibit O2- production generated also by endothelial NO synthase at diminished local L-arginine concentrations accompanying I/R.
Methods and Results During hindlimb I/R (2.5 hours/2 hours), in vivo NO was monitored continuously (porphyrinic sensor), and high-energy phosphates, reduced and oxidized glutathione (chromatography), and I/R injury were measured intermittently. Rabbits receiving human serum albumin (HSA) (controls) were compared with those receiving S-nitroso human serum albumin (S-NO-HSA) beginning 30 minutes before reperfusion for 1 hour or 30 minutes before ischemia for 3.5 hours (0.1 µmol · kg-1 · h- 1). The onset of ischemia led to a rapid increase of NO from its basal level (50±12 nmol/L) to 120±20 and 220±15 nmol/L in the control and S-NO-HSAtreated groups, respectively. In control animals, NO dropped below basal levels at the end of ischemia and to undetectable levels (<1 nmol/L) during reperfusion. In S-NO-HSAtreated animals, maximal NO levels never decreased below basal concentration and on reperfusion were 100±15 nmol/L (S-NO-HSA preischemia group, 175±15 nmol/L). NO supplementation by S-NO-HSA led to partial and in the preischemia group to total preservation of high-energy phosphates and glutathione status in reperfused muscle (eg, preischemia groups: ATP, 30.23±5.02 µmol/g versus control, 15.75±4.33 µmol/g, P<0.0005; % oxidized glutathione, 4.49± 1.87% versus control, 22.84±6.39%, P<0.0001). S-NO-HSA treatment in all groups led to protection from vasoconstriction and reduced edema formation after reperfusion (eg, preischemia groups: interfiber area, 12.94±1.36% versus control, 27.83±1.95%, P< 0.00001).
Conclusions Long-lasting release of NO by S-NO-HSA provides significant protection of skeletal muscle from I/R injury.
Key Words: ischemia reperfusion nitric oxide free radicals
This article has been cited by other articles:
![]() |
S. Hallstrom, M. Franz, H. Gasser, M. Vodrazka, S. Semsroth, U. M. Losert, M. Haisjackl, B. K. Podesser, and T. Malinski S-nitroso human serum albumin reduces ischaemia/reperfusion injury in the pig heart after unprotected warm ischaemia Cardiovasc Res, February 1, 2008; 77(3): 506 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Contaldo, C. Meier, A. Elsherbiny, Y. Harder, O. Trentz, M. D. Menger, and G. A. Wanner Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H274 - H283. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Heiss, T. Lauer, A. Dejam, P. Kleinbongard, S. Hamada, T. Rassaf, S. Matern, M. Feelisch, and M. Kelm Plasma Nitroso Compounds Are Decreased in Patients With Endothelial Dysfunction J. Am. Coll. Cardiol., February 7, 2006; 47(3): 573 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Stamler S-Nitrosothiols in the Blood: Roles, Amounts, and Methods of Analysis Circ. Res., March 5, 2004; 94(4): 414 - 417. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |